"Primum non nocere": the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia.
Publication
, Journal Article
Friedman, DR
Published in: Leuk Lymphoma
March 2013
Duke Scholars
Published In
Leuk Lymphoma
DOI
EISSN
1029-2403
Publication Date
March 2013
Volume
54
Issue
3
Start / End Page
441 / 442
Location
United States
Related Subject Headings
- Male
- Leukemia, Lymphocytic, Chronic, B-Cell
- Immunology
- Humans
- Female
- Antineoplastic Combined Chemotherapy Protocols
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Friedman, D. R. (2013). "Primum non nocere": the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia. Leuk Lymphoma, 54(3), 441–442. https://doi.org/10.3109/10428194.2012.727420
Friedman, Daphne R. “"Primum non nocere": the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia.” Leuk Lymphoma 54, no. 3 (March 2013): 441–42. https://doi.org/10.3109/10428194.2012.727420.
Friedman DR. "Primum non nocere": the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia. Leuk Lymphoma. 2013 Mar;54(3):441–2.
Friedman, Daphne R. “"Primum non nocere": the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia.” Leuk Lymphoma, vol. 54, no. 3, Mar. 2013, pp. 441–42. Pubmed, doi:10.3109/10428194.2012.727420.
Friedman DR. "Primum non nocere": the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia. Leuk Lymphoma. 2013 Mar;54(3):441–442.
Published In
Leuk Lymphoma
DOI
EISSN
1029-2403
Publication Date
March 2013
Volume
54
Issue
3
Start / End Page
441 / 442
Location
United States
Related Subject Headings
- Male
- Leukemia, Lymphocytic, Chronic, B-Cell
- Immunology
- Humans
- Female
- Antineoplastic Combined Chemotherapy Protocols
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences